HY-P99201-1mg
|
MedChemexpress LLC
|
Zilovertamab
|
|
Cancer-programmed cell death
|
|
HY-P99201-10mg
|
MedChemexpress LLC
|
Zilovertamab
|
|
Cancer-programmed cell death
|
|
HY-P99201-5mg
|
MedChemexpress LLC
|
Zilovertamab
|
|
Cancer-programmed cell death
|
|
HY-P99505-1mg
|
MedChemexpress LLC
|
Ziltivekimab [CAS 2226654-05-1]
|
|
|
|
HY-P99505-10mg
|
MedChemexpress LLC
|
Ziltivekimab [CAS 2226654-05-1]
|
|
|
|
HY-P99505-5mg
|
MedChemexpress LLC
|
Ziltivekimab [CAS 2226654-05-1]
|
|
|
|
HY-P99109-1mg
|
MedChemexpress LLC
|
Zimberelimab [CAS 2259860-24-5]
|
|
Cancer-programmed cell death
|
|
HY-P99109-10mg
|
MedChemexpress LLC
|
Zimberelimab [CAS 2259860-24-5]
|
|
Cancer-programmed cell death
|
|
HY-P99109-5mg
|
MedChemexpress LLC
|
Zimberelimab [CAS 2259860-24-5]
|
|
Cancer-programmed cell death
|
|
HY-P99058-1mg
|
MedChemexpress LLC
|
Zolbetuximab [CAS 1496553-00-4]
|
|
Cancer-programmed cell death
|
|
HY-P99058-5mg
|
MedChemexpress LLC
|
Zolbetuximab [CAS 1496553-00-4]
|
|
Cancer-programmed cell death
|
|